v3.25.2
DERIVATIVE LIABILITIES (Tables)
12 Months Ended
Mar. 31, 2025
Debt Instrument [Line Items]  
SCHEDULE OF CONVERTIBLE NOTE AND WARRANT DERIVATIVE LIABILITIES

 

  

Fiscal Year 2025

$

  

Fiscal Year 2024

$

 
Derivative liabilities, beginning of year   1,435,668    759,065 
New issuance [Note 9]   649,533    964,446 
Change in fair value of derivatives during the year   553,208    (92,961)
Reduction due to preferred shares redeemed [Note 9]   (1,159,692)   (194,882)
Derivative liabilities, end of year   1,478,717    1,435,668 
SCHEDULE OF CONVERTIBLE NOTE AND WARRANT DERIVATIVE COMPONENTS VALUATION ASSUMPTIONS

The lattice methodology was used to value the derivative components, using the following assumptions:

  

   Fiscal Year   Fiscal Year 
   2025   2024 
Dividend yield (%)   12    12 
Risk-free rate for term (%)   3.75.1     4.713.7  
Volatility (%)   91.2194.2     71.9119.1  
Remaining terms (Years)   0.172.0    0.252.01  
Stock price ($ per share)   0.241.34     0.983.82  
Convertible Debt [Member]  
Debt Instrument [Line Items]  
SCHEDULE OF CONVERTIBLE NOTE AND WARRANT DERIVATIVE LIABILITIES

 

  

Fiscal Year 2025

$

  

Fiscal Year 2024

$

 
         
Balance beginning of year   991,866    1,008,216 
New Issuance   -    1,224,932 
Conversion to common shares   (509,303)   (45,680)
Convertible note redemption   (59,011)   - 
Change in fair value of derivative liabilities   648    83,184 
End of derivative treatment of warrants   -    (1,278,786)
Convertible note modification   -    - 
Balance end of year   424,200    991,866 
SCHEDULE OF CONVERTIBLE NOTE AND WARRANT DERIVATIVE COMPONENTS VALUATION ASSUMPTIONS

The Monte-Carlo methodology was used to value the convertible note and warrant derivative components, using the following assumptions:

  

    Fiscal Year    Fiscal Year 
    2025    2024 
Risk-free rate for term (%)   0.15.2     4.25.3  
Volatility (%)   91.2194.4     76.2126.6  
Remaining terms (Years)   0.250.5     0.251.49  
Stock price ($ per share)   0.241.45     1.084.20